<?xml version="1.0" encoding="UTF-8"?>
<p>During the ongoing treatment of their patientsâ€™ malignancy, oncologists are expected to address concerns which are related to their symptom load and quality-of-life-related concerns. For many patients, this includes the provision of evidence-based guidance on the use of herbal medicine, including during their conventional anticancer treatment regimen. In this vein, the Clinical Oncology Society of Australia issued a position statement encouraging HCPs to initiate an open discussion with their patients on this practice [
 <xref rid="B58-pharmaceuticals-13-00455" ref-type="bibr">58</xref>]. In a cross-cultural survey of 770 Arab and Jewish oncology patients from northern Israel, both groups of patients stated that the primary expectation from their oncologist was to participate in formulating a complementary traditional medicine treatment plan, to be provided within the conventional oncology department [
 <xref rid="B59-pharmaceuticals-13-00455" ref-type="bibr">59</xref>].
</p>
